Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Additive Value of Biological and Electrocardiographic Biomarkers for Risk Stratification in Hypertension

NCT03068364 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT03068364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03068364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Additive Value of Biological and Electrocardiographic Biomarkers for Risk Stratification in Hypertension
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
November 3, 2016
Completion date
February 17, 2017
Enrollment
1,600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension